Aim High And Keep Pushing: China Biotech Dealmakers Borrow Page From Trump

Recent biotech investment deals involving WuXi, Oncologie and Siranomics show Chinese investors are becoming increasingly bold and savvy in betting on innovative assets both inside and outside the country.